Explore the recent advances in fuzzing, including the challenges and opportunities it presents for high-integrity software ...
Black patients with chronic kidney diseases have faced historically longer waiting times for kidney transplants due to an ...
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially ...
Hormones have become the bogeyman du jour, with a booming crop of pseudo-treatments promising to regulate everything.
Tracking The Right Global Warming MetricWhen it comes to climate change induced by greenhouse gases, most of the public’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results